Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria

The Aliskiren in the Evaluation of Proteinuria in Diabetes (AVOID) trial demonstrated that adding aliskiren, an oral direct renin inhibitor, at a dosage of 300 mg/d to the highest approved dosage of losartan and optimal antihypertensive therapy reduces albuminuria over 6 mo among patients with type...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Delea, Thomas E., Sofrygin, Oleg, Palmer, James L., Lau, Helen, Munk, Veronica C., Sung, Jennifer, Charney, Alan, Parving, Hans-Henrik, Sullivan, Sean D.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Nephrology 2009
Fag:
Clinical Epidemiology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2754109/
https://ncbi.nlm.nih.gov/pubmed/19762496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2008111144
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker